Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9539293 | 0.81 | IGF1R (0.32) | — | |
| SCHEMBL21809013 | 0.80 | — | — | |
| SCHEMBL18190318 | 0.79 | LMNA (0.31) | — | |
| SCHEMBL9657794 | 0.77 | — | — | |
| SCHEMBL9657791 | 0.77 | — | — | |
| SCHEMBL6438670 | 0.74 | IGF1R (0.31) | — | |
| SCHEMBL8719717 | 0.71 | IGF1R (0.31) | — | |
| SCHEMBL18190401 | 0.70 | CDK2 (0.36) | — | |
| SCHEMBL23403823 | 0.70 | PGR (0.39) | — | |
| SCHEMBL7173883 | 0.70 | SMN1; SMN2 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8247392-B2 | Materials for selective trapping of carbon monoxide | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2012-08-21 | — | — | US | disclosed |
| US-7521551-B2 | Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy | MIRAVANT PHARMACEUTICALS, INC. (US) | 2009-04-21 | — | — | US | disclosed |
| US-20080275232-A1 | CHLORINS POSSESSING FUSED RING SYSTEMS USEFUL AS PHOTOSELECTIVE COMPOUNDS FOR PHOTODYNAMIC THERAPY | MIRAVANT PHARMACEUTICALS, INC. | 2008-11-06 | — | — | US | disclosed |
| EP-1414823-B1 | MATERIALS FOR SELECTIVE TRAPPING OF CARBON MONOXIDE | AIR LIQUIDE (FR) | 2007-05-02 | — | — | EP | disclosed |
| US-20060287195-A1 | Novel materials for selective trapping of carbon minixide | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2006-12-21 | — | — | US | disclosed |
| US-7112671-B2 | Non-symmetric tripyrranes in the synthesis of novel macrocycles | PHARMACYCLICS, INC. (US) | 2006-09-26 | — | — | US | disclosed |
| EP-1247655-B1 | OPTICAL RECORDING MEDIUM AND NOVEL AZAPORPHYRIN COMPOUNDS | MITSUI CHEMICALS INC (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1262966-B1 | Optical recording medium and novel azaporphyrin compound | MITSUI CHEMICALS INC (JP) | 2006-04-12 | — | — | EP | disclosed |
| US-6969764-B2 | Mono-, di-, and triazaporphyrin compounds optionally in the form of a metal or metalloid complex | MITSUI CHEMICALS, INC. (JP) | 2005-11-29 | — | — | US | disclosed |
| US-20030232800-A1 | Non-symmetric tripyrranes in the synthesis of novel macrocycles | UNIVERSITY OF TEXAS | 2003-12-18 | — | — | US | disclosed |
| US-20030194646-A1 | Mono-, di-, and triazaporphyrin compounds optionally in the form of a metal or metalloid complex | MITSUI CHEMICALS, INC. (JP) | 2003-10-16 | — | — | US | disclosed |
| EP-1262966-A2 | Optical recording medium and novel azaporphyrin compound | Mitsui Chemicals, Inc. (JP) | 2002-12-04 | — | — | EP | disclosed |
| EP-1247655-A1 | OPTICAL RECORDING MEDIUM AND NOVEL AZAPORPHYRIN COMPOUNDS | Mitsui Chemicals, Inc. (JP) | 2002-10-09 | — | — | EP | disclosed |
| WO-2002017925-A1 | NON-SYMMETRIC TRIPYRRANNES IN THE SYNTHESIS OF NOVEL MACROCYCLES | PHARMACYCLICS, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| EP-0357059-A2 | Electrically conductive polymer mixtures | WACKER-CHEMIE GMBH (DE) | 1990-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275232-A1 | CHLORINS POSSESSING FUSED RING SYSTEMS USEFUL AS PHOTOSELECTIVE COMPOUNDS FOR PHOTODYNAMIC THERAPY | PPOX, HMBS, DDT | PIM1 3399/4885PIM3 2873/4885 |
| US-20060287195-A1 | Novel materials for selective trapping of carbon minixide | CBR1, CBR3, FOXM1 | PIM1 1293/4885PIM3 1372/4885 |
| US-20030232800-A1 | Non-symmetric tripyrranes in the synthesis of novel macrocycles | NUP188, TRIP13, NUP160 | PIM1 1840/4885PIM3 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.